Abstract:Immunoglobulin secretion is modulated by a competition between use of a weak promoter proximal poly(A) site and a non-consensus splice site in the last secretory-specific exon of the heavy chain pre-mRNA. RNA polymerase II transcription elongation factor ELL2, induced in plasma cells, enhanced both polyadenylation and exon skipping with the Igh gene and reporter constructs. Lowering ELL2 expression by hnRNP F transfection or siRNA reduced secretory-specific forms of IgH mRNA. ELL2 and polyadenylation factor Cs… Show more
“…Yeast sub1 has been shown to interact with all the CTD kinases and it may have multiple actions throughout the transcription cycle (Garcia, Rosonina et al 2010). Surprisingly, our experiments did not show a role for PC4/ sub1 in directing alternative Igh mRNA expression (Martincic, Alkan et al 2009) and below.…”
Section: Rna Polymerase II Phosphorylation Is Altered On the Igh Genecontrasting
confidence: 65%
“…The CCNC complex of cyclin C and cdk8 along with PC4/ sub1 are induced by IRF4 in multiple myeloma a tumor of the plasma cells (Shaffer, Emre et al 2008) and could act on the Igh gene to regulate transcription. We re-examined the micro-array data on gene expression in B versus plasma cells that we published previously (Martincic, Alkan et al 2009) to concentrate on transcription elongation factors. The data are shown Table 1.…”
Section: Differential Expression Of Factors In a Number Of Pathways Smentioning
confidence: 99%
“…We showed that treatment of plasma cells with DRB inhibits ser-2 phosphorylation and causes the unmodified RNAP-II on the Ig heavy chain in plasma cells to stall near the 5'-end of the Ig gene (Shell, Martincic et al 2007) and Figure 3. DRB also causes the decreased association of ELL2, PC4 and the polyadenylation factor CstF-64, suggesting that their binding to RNAP-II require the ser-5 and ser-2 (Shell, Martincic et al 2007), normal and DRB treatment and siell2 data (Martincic, Alkan et al 2009). The error bars and statistics showing significance are detailed in those publications and omitted here for clarity.…”
Section: Rnap-ii Ctd Phosphorylationmentioning
confidence: 99%
“…Changes in the level of rate-limiting, trans acting factors, like CstF-64 following lipopolysaccharide stimulation in B-cells (Takagaki, Seipelt et al 1996) or macrophages (Shell, Hesse et al 2005) or in the cell cycle (Martincic, Campbell et al 1998), can also increase mRNA polyadenylation (Getz, Elder et al 1976). Changes in the level of ELL2, a transcription elongation factor, increase use of the first poly(A) site in the Igh gene (Martincic, Alkan et al 2009), an important step for plasma cell development. Therefore, the throughput of initiated transcripts to polyadenylated, mature mRNA is limited by a.)…”
“…Yeast sub1 has been shown to interact with all the CTD kinases and it may have multiple actions throughout the transcription cycle (Garcia, Rosonina et al 2010). Surprisingly, our experiments did not show a role for PC4/ sub1 in directing alternative Igh mRNA expression (Martincic, Alkan et al 2009) and below.…”
Section: Rna Polymerase II Phosphorylation Is Altered On the Igh Genecontrasting
confidence: 65%
“…The CCNC complex of cyclin C and cdk8 along with PC4/ sub1 are induced by IRF4 in multiple myeloma a tumor of the plasma cells (Shaffer, Emre et al 2008) and could act on the Igh gene to regulate transcription. We re-examined the micro-array data on gene expression in B versus plasma cells that we published previously (Martincic, Alkan et al 2009) to concentrate on transcription elongation factors. The data are shown Table 1.…”
Section: Differential Expression Of Factors In a Number Of Pathways Smentioning
confidence: 99%
“…We showed that treatment of plasma cells with DRB inhibits ser-2 phosphorylation and causes the unmodified RNAP-II on the Ig heavy chain in plasma cells to stall near the 5'-end of the Ig gene (Shell, Martincic et al 2007) and Figure 3. DRB also causes the decreased association of ELL2, PC4 and the polyadenylation factor CstF-64, suggesting that their binding to RNAP-II require the ser-5 and ser-2 (Shell, Martincic et al 2007), normal and DRB treatment and siell2 data (Martincic, Alkan et al 2009). The error bars and statistics showing significance are detailed in those publications and omitted here for clarity.…”
Section: Rnap-ii Ctd Phosphorylationmentioning
confidence: 99%
“…Changes in the level of rate-limiting, trans acting factors, like CstF-64 following lipopolysaccharide stimulation in B-cells (Takagaki, Seipelt et al 1996) or macrophages (Shell, Hesse et al 2005) or in the cell cycle (Martincic, Campbell et al 1998), can also increase mRNA polyadenylation (Getz, Elder et al 1976). Changes in the level of ELL2, a transcription elongation factor, increase use of the first poly(A) site in the Igh gene (Martincic, Alkan et al 2009), an important step for plasma cell development. Therefore, the throughput of initiated transcripts to polyadenylated, mature mRNA is limited by a.)…”
“…This process is regulated by levels of CStF-64, which are more limited in pre-B cells than in mature B cells (Takagaki et al 1996;Takagaki and Manley 1998). Also, Pol II elongation factors may act to modulate this PAS switch (Martincic et al 2009). A similar type of APA regulation exists for the calcitonin gene.…”
Section: Alternative Pas (Apa) Define Different Mrna 39 Utrsmentioning
Polyadenylation [poly(A)] signals (PAS) are a defining feature of eukaryotic protein-coding genes. The central sequence motif AAUAAA was identified in the mid1970s and subsequently shown to require flanking, auxiliary elements for both 39-end cleavage and polyadenylation of premessenger RNA (pre-mRNA) as well as to promote downstream transcriptional termination. More recent genomic analysis has established the generality of the PAS for eukaryotic mRNA. Evidence for the mechanism of mRNA 39-end formation is outlined, as is the way this RNA processing reaction communicates with RNA polymerase II to terminate transcription. The widespread phenomenon of alternative poly(A) site usage and how this interrelates with pre-mRNA splicing is then reviewed. This shows that gene expression can be drastically affected by how the message is ended. A central theme of this review is that while genomic analysis provides generality for the importance of PAS selection, detailed mechanistic understanding still requires the direct analysis of specific genes by genetic and biochemical approaches.
Recent advances reveal mRNA 3′end processing as a highly regulated process that fine-tunes posttranscriptional gene expression. This process can affect the site and/or the efficiency of 3′end processing, controlling the quality and the quantity of substrate mRNAs. The regulation of 3′end processing plays a central role in fundamental physiology such as blood coagulation and innate immunity. In addition, errors in mRNA 3′end processing have been associated with a broad spectrum of human diseases, including cancer. We summarize and discuss the paradigmatic shift in the understanding of 3′end processing as a mechanism of posttranscriptional gene regulation that has reached clinical medicine.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.